💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

US STOCKS-Wall St rises after payrolls data

Published 09/03/2010, 10:46 AM
Updated 09/03/2010, 10:48 AM

* Payrolls better than expected

* ISM shows services sector slowing

* Indexes up: Dow 0.8 pct, S&P 0.9 pct, Nasdaq 1 pct

* For up-to-the-minute market news see [STXNEWS/US] (Adds ISM data, quote, updates prices)

By Chuck Mikolajczak

NEW YORK, Sept 3 (Reuters) - Wall Street advanced on Friday after a better-than-expected jobs report lifted investor optimism on the economy but gains were checked after data showed services sector activity slowed.

Wall Street initially climbed more than 1 percent after the Labor Department said employment fell for a third straight month in August, but the job losses were far less than expected. Also, private employers added more staff than forecast. For details, see [ID:nN02227856]

The major indexes trimmed gains after the Institute for Supply Management said the U.S. non-manufacturing sector grew in August for an eighth straight month but at a slower pace and below forecast. [ID:nN03111828]

"The jobs number is obviously a much bigger number for the market than the ISM number, but I wouldn't completely ignore it," said Marc Pado, U.S. market strategist at Cantor Fitzgerald & Co in San Francisco.

"It's not a great number and shows we are still bumping along the bottom here, really."

The Dow Jones industrial average <.DJI> gained 80 points, or 0.78 percent, to 10,400.10. The Standard & Poor's 500 Index <.SPX> rose 9.47 points, or 0.87 percent, to 1,099.57. The Nasdaq Composite Index <.IXIC> advanced 22.60 points, or 1.03 percent, to 2,222.61.

Take-Two Interactive Inc jumped nearly 10 percent to $9.71 after the video gamemaker's quarterly profit smashed past expectations, and it raised its forecast.

Campbell Soup Co shed 3.5 percent to $36 after posting lower-than-expected quarterly sales and forecast growth below its long-term target as it grapples with a weak economy. [ID:nN03271791]

Celldex Therapeutics Inc tumbled 30 percent to $3.33 after Pfizer Inc ended a codevelopment deal on Celldex's lead product, a cancer vaccine. [ID:nSGE6820ET]

^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^

For a Reuters Insider take on the jobs report see [http://link.reuters.com/vef98n]

^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ (Reporting by Chuck Mikolajczak; editing by Jeffrey Benkoe)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.